Régis Pouillot 1, Loan Nguyen 2, Sherri Dennis 1 1 FDA/CFSAN, USA 2 Health Canada - Santé Canada Quantitative Assessment of the Risk of Listeriosis from.

Slides:



Advertisements
Similar presentations
UPDATE: Assessment of the Relative Risk to Public Health from Foodborne Listeria monocytogenes Among Selected Categories of Ready-to-Eat Foods Robert L.
Advertisements

The Role of Predictive Microbiology in Microbial Risk Assessment Robert L. Buchanan U.S. DHHS Food and Drug Administration Center for Food Safety and Applied.
Rafael Bastos (1), Paula Bevilacqua (2), Richard Gelting (2), Demétrius Viana (1), João Pimenta (1) (1) University of Viçosa, Brazil (2) US Center for.
Listeria monocytogenes: An Overview Catherine N. Cutter Department of Food Science Penn State University ©2006 Department of Food Science - College of.
Exponent, Food and Chemicals Practice, formerly Novigen Sciences, Inc. Food Consumption Data in Microbiological Risk Assessment Barbara J. Petersen and.
How risk assessors and risk managers have utilized available data to support decision making Listeria and Vibrio Risk Assessment Examples Risk Assessment.
Controlling Listeria monocytogenes (Lm) in Retail Delicatessens
1 Webinar: Assessment of the risk of human salmonellosis associated with the consumption of tree nuts Monday, July 22 nd 12 – 1 pm ET.
Listeria in the Dairy and Cold-Smoked Salmon Industries Presented by Rebecca Robertson October 9, 2008.
Lessons Learned in Initiating and Conducting Risk Assessments within a Risk Analysis Framework: A FDA/CFSAN Approach Robert Buchanan DHHS Food and Drug.
Specific Emerging Topics in Food Microbiology I Listeria monocytogenes in seafood I 27, May 2013-SS 1 Listeria monocytogenes in seafood Mansooreh Jami,
Preventing Introduction, Growth and Cross-Contamination of Listeria monocytogenes ©2006 Department of Food Science - College of Agricultural Sciences at.
Food Safety Microbiology - February, of 27 Quantitative Risk Assessment Don Schaffner, Ph.D. Rutgers, The State University of NJ.
1 Quantitative Microbial Risk Assessment (QMRA) Salmonella spp. in broiler chicken Suphachai Nuanualsuwa n DVM, MPVM, PhD.
Food Safety Risk Assessment - PubH of 40 Overview of 3 published risk assessments Don Schaffner, Ph.D. Rutgers, The State University of NJ.
United States Department of Agriculture Food Safety and Inspection Service Role of Economics in Pathogen Control Regulations Daniel Engeljohn, Ph.D. Office.
The Safety of Raw Milk Consumption By Desiree Sanchez & Elizabeth Schuerman.
Janell R. Kause, MPH/MPP U.S. Department of Agriculture Food Safety and Inspection Service Conducting Risk Assessments to Guide Food Safety Decisions Addressing.
U.S. Department of Agriculture Office of Food Safety Food Safety and Inspection Service Winston Felton, D.V.M. Dearborn Circuit Supervisor Madison District.
Food Safety Management at the Retail Level Katherine MJ Swanson, PhD Vice President Food Safety May 28, 2008 Campinas, Brazil IAFP Latin American Symposium.
Milk By: Allison Huang,Yun Ting Xu,Katerina Kountouris,Yinan Cho, Qiujing Hu Group #2.
Interagency Retail Listeria monocytogenes Risk Assessment Data Sources, Data Review, and Data Gaps - Régis POUILLOT – CFSAN/FDA/HHS June 23, 2009.
Food safety and cheese International Food Safety Consultancy Dr.W.R. Marsman.
Sarah McLean Raw Milk: Does It Do A Body Good?. Swinburne SCIENCE | TECHNOLOGY | INNOVATION | BUSINESS | DESIGN -Milk that has not been pasteurised or.
1 Thailand Researches in Microbiological Risk Assessment : Past & Present Suphachai Nuanualsuwa n DVM, MPVM, PhD.
Perspectives on Pathogen Performance Standards Richard C. Whiting FDA, CFSAN College Park, MD December 10, SRA Annual Meeting.
1 Risk Surveillance and Assessment of Food Safety in Shanghai.
Environmental Risk Analysis
Food Safety Regulations Canada Dr Ruby Lee. Food Safety Regulations - Canada 1. Health Canada Policy on Listeria monocytogenes in RTE Mushroom 2. Safe.
Yuhuan Chen, Sherri Dennis, and Sherri McGarry Food and Drug Administration Current Approach to FSMA Section 204: Designating High-Risk Foods for Tracing.
FSIS Listeria Risk Assessment Daniel Gallagher Dept. of & Environmental Engineering Dept. of Civil & Environmental Engineering Virginia Tech Eric Ebel.
Challenges in data needs for assessment of food product risk and attribution of foodborne illnesses to food products in the United States Chuanfa Guo,
FDA Tree Nut Risk Assessment and Human Salmonellosis
SMMSS - Support to Modernisation of Mongolia Standardisation System Food Chain Risk Assessment and Management - Seminar on Food Safety Ulaanbaatar / Mongolia.
FAO/WHO Codex Training Package Module 3.2 FAO/WHO CODEX TRAINING PACKAGE SECTION THREE – BASICS OF NATIONAL CODEX ACTIVITIES 3.2 How to develop national.
Incorporating risk metrics into food safety regulations: L. monocytogenes in ready-to-eat deli meats 1 Daniel Gallagher Virginia Tech 12th Annual Joint.
Multimedia Assessment for New Fuels: Stakeholders’ Meeting September 13, 2005 Sacramento, CA Dean Simeroth, California Air Resources Board Dave Rice, Lawrence.
BASELINE software tool for calculation of microbiological criteria and risk management metrics for selected foods and hazards WP6 Model Development Final.
Furan in Food Summary and Charge to the FAC and SCNT Terry C. Troxell, Ph.D. Director Office of Plant and Dairy Foods FDA Center for Food Safety and Applied.
Risk Mapping and Listeria monocytogenes Transfer in Retail Delis Karin Hoelzer, PhD FDA / Cornell University Interagency Risk Assessment - L. monocytogenes.
2013 IRAC/NCAC-SRA/ORACA Risk Analysis Workshop: Advancing Analysis Washington, DC – USDA South Building – June 18, 2013 Janell Kause (FSIS) Sherri Dennis.
Major Components of FDA’s Action Plan for Acrylamide Richard Canady, PhD DABT US Food and Drug Administration Center for Food Safety and Applied Nutrition.
P2-78: Generic Modeling Approach for Quantitative Microbial Risk Assessment Thomas P. Oscar, USDA, ARS/1890 Center of Excellence in Poultry Food Safety.
Modeling for Quantitative Microbial Risk Assessment
Interagency Retail Listeria monocytogenes Risk Assessment Background, Scope, and Purpose Janell Kause Food Safety and Inspection Service June 23, 2009.
Background on Furan in Foods Nega Beru, Ph.D. Director, Division of Plant Product Safety Office of Plant and Dairy Foods Center for Food and Applied Nutrition.
Risk Assessment* and Zoonotic Implications Yvonne Nadler DVM MPH April 6, 2011 * THE FUN STUFF.
USDA, ARS Workshop Poultry Food Assess Risk Model (Poultry FARM)
Using Models to Assess Microbial Risk: A Case Study CAMRA August 10 th, 2006.
Lettuce, EHEC and Irrigation Water: Apply FDA-iRISK for Rapid Risk Assessment Yuhuan Chen, Sherri Dennis, Karin Hoelzer, and Régis Pouillot Food and Drug.
Risk Assessment.
Using risk assessment to evaluate risk-based microbiological criteria Introduction Microbiological criteria (MCs) are increasingly used as an instrument.
Régis POUILLOT, DVM, PhD FDA/CFSAN Draft - Interagency Listeria monocytogenes in Retail Delicatessens Risk Assessment Part 1: Design - Data Sources – Modeling.
Dan Gallagher, PhD, P.E. Virginia Tech Draft - Interagency Listeria monocytogenes in Retail Delicatessens Risk Assessment Part 2: Results Interagency Risk.
Data Needed to Measure HACCP Impacts on Public Health Jack Guzewich, R.S., M.P.H. Pathogen Reduction Dialogue Panel 2 May 6, 2002.
Figure 1 P176: A Quantitative Risk Assessment Model for Salmonella and Whole Chickens at Retail Thomas P. Oscar, Agricultural Research Service, USDA, 1124.
1 Historical Perspective on FDA’s Listeria Approach Mickey Parish, Ph.D. Senior Advisor for Microbiology FDA/CFSAN, Office of Food Safety JIFSAN Advisory.
Scientific Perspective on Listeria monocytogenes in Ready-to-Eat Food
Safety-Based Use-By Date Labeling Robert L. Buchanan DHHS Food & Drug Administration Center for Food Safety & Applied Nutrition.
United States Department of Agriculture Food Safety and Inspection Service FSIS Risk Assessments for E. coli O157:H7 Dr. Carl Schroeder Office of Public.
Innovative Modeling Approaches Applicable to Risk Assessments Thomas P. Oscar, PhD USDA, ARS Princess Anne, MD, USA.
What is Risk Assessment? Janell Kause FSIS Risk Assessment Division USDA Listeria Public Meeting February 26, 2003.
Experiences with Controlling Listeria monocytogenes in Ready- to-Eat Food Processes W. Payton Pruett, Jr., Ph.D. ConAgra Refrigerated Foods USDA Listeria.
Sodium Reduction: FDA’s Voluntary Initiative Susan Mayne, Ph.D., Director Center for Food Safety and Applied Nutrition Food and Drug Administration 1.
Evaluation of Microbiological Risks Associated with Direct Potable Reuse (DPR) Water Microbiology Conference 2016 University of North Carolina May 2016.
Olivier KAMANA (DVM,MSc., PhD)
FDA Commissioner’s Fellow
Food poisoning: Listeria
International Food Safety Consultancy Dr.W.R. Marsman
FDE 101-Basic Concepts in Food Engineering
Presentation transcript:

Régis Pouillot 1, Loan Nguyen 2, Sherri Dennis 1 1 FDA/CFSAN, USA 2 Health Canada - Santé Canada Quantitative Assessment of the Risk of Listeriosis from Soft-ripened Cheese Consumption in the United States and Canada. MiniSRA meeting, 2013 June 18 th, 2013

Background The United States and Canada continue to experience sporadic illness and outbreaks of listeriosis associated with the consumption of cheese FDA and Health Canada (HC) continue to evaluate the safety of cheese, particularly cheese made from unpasteurized milk  FDA and HC carried out a QMRA to evaluate the effectiveness of and the public health impact of processing and intervention strategies to reduce or prevent Listeria monocytogenes in soft-ripened cheeses.

Scope Pathogen: Listeria monocytogenes Food: Camembert, as an example of soft-ripened cheese Population of Interest: – General population of the U.S. and Canada – Subpopulations identified as at-risk in both countries Endpoint: Invasive listeriosis (primary) Risk metric: Probability of invasive listeriosis per soft-ripened cheese serving

Baseline – “Pasteurized-milk cheese”, i.e. Soft-ripened cheese made from pasteurized milk, “stabilized process” Vs. Alternatives – “Raw-milk cheese”, i.e. Soft-ripened cheese made from raw milk, “traditional process”, Farmstead scale – “Raw-milk cheese” or “Pasteurized-milk cheese” according to various mitigation strategies

Framework / Model / Data Framework: Codex Alimentarius, FDA, HC Fully quantitative risk assessment – Second-order Monte Carlo simulation Model structure based on – Literature, Previous risk assessments, Expert sources Data based on – Literature, Government surveys, Specific expert elicitations Exposure assessment L. monocytogenes consumed Exposure assessment L. monocytogenes consumed Hazard Characterization - Dose Response - Hazard Characterization - Dose Response - Risk Characterization

Hazard Characterization - Dose Response - Hazard Characterization - Dose Response - – Adapted from the FAO/WHO (2004) risk model – Exponential dose-response models considering uncertainty Blue: Susceptible population Red: Non-susceptible population Log 10 (prob of illness)

Exposure assessment L. monocytogenes consumed Exposure assessment L. monocytogenes consumed On Farm -(Cross) contamination- -Growth- -Mixing- -Removal- On Farm -(Cross) contamination- -Growth- -Mixing- -Removal- Cheese Processing -Growth- -Inactivation- -Mixing- - Partitioning- -Removal- - Cross Contamination- Cheese Processing -Growth- -Inactivation- -Mixing- - Partitioning- -Removal- - Cross Contamination- Transport and Marketing -Growth- Transport and Marketing -Growth- At Retail -Growth- At Retail -Growth- At Home -Growth- -Partitioning- At Home -Growth- -Partitioning- Pasteurization

Baseline Model No bacteria from milk (“full” pasteurization) Environmental contamination before aging – Prevalence and level inferred from Gombas et al, 2003 (+ backcalculation) Bacterial growth from contamination to consumption – Lag phase: Relative Lag Time concept – Growth during ripening: complex model considering T, pH, a w and interactions – Growth during aging: square root model – Growth in solid media (vs. liquid) is considered – Parameters: meta-analysis of the available literature data Partition from serving to serving Transport and Marketing -Growth- Transport and Marketing -Growth- At Retail -Growth- At Retail -Growth- At Home -Growth- -Partitioning- At Home -Growth- -Partitioning- Aging -Growth- Aging -Growth- Packaging Full pasteurization Environmental contamination No Lm On Farm Cheese processing 8

Gombas et al. (2003 ) Number of Lm in a 250g cheese at retail in North-America Lm concentration in North-America at retail ln(c) ~ Normal( ,  2 ) Number of Lm in a 250g cheese before aging Number of Lm in a 250g cheese at retail Number of Lm in a 250g cheese at retail Number of Lm in a 250g cheese before aging Inferences Simulations - Growth during aging - Growth during aging - Growth during marketing - Growth during marketing - Growth during storage at retail - Growth during storage at retail + Growth during aging + Growth during aging + Growth during marketing + Growth during marketing + Growth during storage at retail + Growth during storage at retail Prevalence of contaminated cheeses in North-America at retail Beta( ,  ) Prevalence of contaminated cheeses in North-America Prevalence of contaminated cheeses before aging Prevalence of contaminated cheeses at retail = Environmental Contamination RetailManufacturing

Alternative Scenario: Raw-milk Cheeses Includes a farm model with – Mastitic cows and/or environmental contamination on farm – Mixing of milk from various cows – Growth in milk: in farm tank, tanker truck and dairy silo Growth in cheese considers the lower pH in “traditional” cheese process and regulatory requirement of at least 60 days storage prior to retail Considering additionally – Partition during cheese formation – Inactivation / Growth in cheeses during ripening On Farm -(Cross) contamination- -Growth- -Mixing- On Farm -(Cross) contamination- -Growth- -Mixing- Cheese processing - Growth- - Inactivation- - Mixing- - Partitioning- Cheese processing - Growth- - Inactivation- - Mixing- - Partitioning- Transport and Marketing -Growth- Transport and Marketing -Growth- At Retail -Growth- At Retail -Growth- At Home -Growth- -Partitioning- At Home -Growth- -Partitioning- Lm from mastitic cows Lm from environmental contamination before packaging Lm from environmental contamination in farm 10

Farm 2 Tanker truck Farm 1 Cow 1 Cow 2 Cow … Quarter 2 Quarter 1 Quarter 3 Quarter 4 Dairy silo Number of cows per farm Milk production Prevalence of positive farm bulk tank Level of contamination in positive bulk tank Storage time and temperature in farm bulk tank Probability of mastitis in the herd given a positive bulk tank Number of mastitic cows on L. monocytogenes positive farm Level of contamination in raw milk from mastitic cow Number of infected quarters given mastitis Yield reduction given mastitis Data Process Growth characteristics Storage time and temperature in tanker truck Storage time and temperature in dairy silo Milk Contamination

Other Alternative Scenarios Raw-milk cheese, no 60-day aging restriction Raw-milk cheese, mild treatment that reduces the bacterial load in milk by 3-log 10 Raw-milk cheese, test (and discard if positive) milk at every milking – 25 ml of raw milk from the farm tank Raw-milk cheese, test (and discard if positive) every lot of cheese – Composite sample of 25g from 5 cheeses 12

RESULTS

Baseline L. monocytogenes cells per gram at process pathway steps in contaminated cheeses  Most of the growth occurs after retail Mean >> 95 th percentile  Great (serving to serving at random) variability in this model

Variability Vs. uncertainty Variability Ratio (B/A) = 8 005Uncertainty Ratio (C/A) = 9 Overall Uncertainty Ratio (D/A) =  Variability >> (considered) Uncertainty in this model

Baseline Results (fully) pasteurized milk, “stabilized” cheese 16 Estimated number of servings resulting in one case of invasive listeriosis. CanadaUnited States Elderly138 million136 million Pregnant56 million55 million Immunocompromised163 million193 million General population7,290 million8,644 million

17 Estimated number of servings resulting in one case of invasive listeriosis. (X-fold increased risk of invasive listeriosis vs. pasteurized milk soft-ripened cheese). CanadaUnited States Elderly2.6 Million servings (×53)1.2 Million servings (×112) Pregnant1.1 Million servings (×52) servings (×96) Immunocompromised2.4 Million servings (×69)1.2 Million servings (×157) General population105 Million servings (×69)55 Million servings (×157) Baseline Results raw milk, “traditional” cheese

Alternative Scenarios for Raw Milk cheese (Elderly population, Canada) 18 Mean Risk Higher than Pasteurized-milk Mean Risk Lower than Pasteurized-milk

19 Mean Risk Higher than Pasteurized-milk Mean Risk Lower than Pasteurized-milk Alternative Scenarios for Raw Milk cheese (Elderly population, Canada)

SUMMARY - CONCLUSIONS

“Complex Models to Answer Complex Questions” Extend the FDA/FSIS 2003 Risk Assessment from “store-to-fork” to “farm-to-fork” Comparing risk of listeriosis from pasteurized- vs. raw-milk cheese needed to consider – A full farm to fork model Contamination in farm vs. in-plant contamination – A complex growth model considering Lag time Traditional vs. Stabilized manufacturing process Interactions between environmental parameters Growth in solid media Limitations – Caveats – Conclusions limited to the considered pathogen and the considered cheese – Dose-response

Take-home message Variability in the Risk linked to the subpopulation – Within a country: linked to the dose-response – Between countries: different consumption pattern, raw-milk prevalence Pasteurized-milk cheese: – Time / Temperature in refrigerator is the key factor that increases the risk of listeriosis from contaminated cheeses – The best strategy is nevertheless to reduce environmental contamination The risk from consumption of raw milk made cheeses is much higher than the risk for pasteurized milk cheeses in the U.S. and Canada – × 50 to 160 times higher The 60 day aging regulation could increase the risk of listeriosis for raw- milk soft-ripened cheeses For raw milk made cheeses, testing every cheese lot is the only alternative that reduces the risk below the level of risk observed in pasteurized milk made cheeses 22

Current / Next step Peer reviewed Draft report made available Public comments  Ended April 29 th  96 comments posted  Now Considering the comments

Acknowledgments Mark Smith, Health Canada FDA and HC Risk managers Project supported in part by an appointment to the Research Participation Program at the CFSAN administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U.S. Department of Energy and the US FDA.